Earlybird UNI-X is a venture capital firm that focuses on backing early-stage entrepreneurs in Europe, specifically from Pre-Seed to Series A. They seek to build impactful and lasting companies with groundbreaking technologies. Their investment strategy involves providing financial resources, strategic support, and access to an international network to help portfolio companies scale and achieve success. They aim to be a partner from 'Day 1', providing support as board members and confidants. The firm invests in emerging tech sectors, including fintech and nuclear fusion. They focus on companies with potential for significant impact and are willing to take risks on early-stage ventures. They also seem to focus on deep tech, insurtech, and consumer tech companies. They offer initial ticket sizes up to €12m, and focus on Pre-Seed (20%), Seed (60%), and Series A (20%). They have a dedicated Earlybird Health branch as well. They claim to be specialists in innovation and look for independent thinkers and offer the support and resources to create lasting impact.
Preferred startup development maturity for initial funding deployment.
DeepTech, FinTech, InsurTech, ConsumerTech
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...